Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ELPLAT for Rectal cancer: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 14 adverse event reports in the FDA FAERS database where ELPLAT was used for Rectal cancer.

Most Reported Side Effects for ELPLAT

Side Effect Reports % Deaths Hosp.
Interstitial lung disease 12 21.1% 2 6
Neuropathy peripheral 10 17.5% 2 6
Neutrophil count decreased 8 14.0% 2 3
White blood cell count decreased 7 12.3% 3 3
Hyperammonaemia 6 10.5% 1 2
Diarrhoea 5 8.8% 3 1
Nausea 5 8.8% 2 2
Platelet count decreased 5 8.8% 1 1
Splenomegaly 5 8.8% 0 3
Stomatitis 5 8.8% 3 2

Other Indications for ELPLAT

Colon cancer (23) Colon cancer metastatic (5) Pancreatic carcinoma (5)

Other Drugs Used for Rectal cancer

CAPECITABINE (2,976) OXALIPLATIN (2,402) FLUOROURACIL (1,610) BEVACIZUMAB (1,546) TIPIRACIL\TRIFLURIDINE (1,297) IRINOTECAN (985) LEUCOVORIN (660) CETUXIMAB (542) REGORAFENIB (505) PANITUMUMAB (374)

Related Pages

ELPLAT Full Profile All Rectal cancer Drugs ELPLAT Demographics ELPLAT Timeline